Evidence map›Paper›PMID 40172476›Full record

ArticleNeuro-oncology2025

AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: Analysis of 124 histologically assessed lesions.

Gaia Ressa, Riccardo Levi, Giovanni Savini, Luca Raspagliesi, Elena Clerici, Luisa Bellu, Luca A Cappellini, Marco Grimaldi, Saverio Pancetti, Beatrice Bono and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Radionecrosis risk and local control after CyberKnifeRadiation oncology (London, England) · 2026
    Article
  4. RN-DFrontiers in artificial intelligence · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Gaia RessaNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Riccardo LeviNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0001-9030-0071
Giovanni SaviniNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Luca RaspagliesiNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-6708-7003
Elena ClericiRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-1765-863X
Luisa BelluNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-7286-4014
Luca A CappelliniNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Marco GrimaldiNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Saverio PancettiPathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0001-5582-6131
Beatrice BonoNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-6514-6188
Andrea FranziniNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Marco RivaNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Bethania FernandezPathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Maximilian NiyaziCenter for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany.
Federico PessinaNeurosurgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Giuseppe MinnitiDepartment of Radiological Sciences, Oncology, and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.
Pierina NavarriaRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-6913-1442
Marta ScorsettiRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0003-0320-559X
Letterio S PolitiNeuroradiology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Funding

IRCCS Humanitas Research HospitalItalian Ministry of Health
6 · The paper itself

Abstract

backgroundDifferentiating radionecrosis from neoplastic progression after stereotactic radiosurgery (SRS) for brain metastases is a diagnostic challenge. Previous studies have often been limited by datasets lacking histologically confirmed diagnoses. This study aimed to develop automated models for distinguishing radionecrosis from disease progression on brain MRI, utilizing cases with definitive histopathological confirmation.

methodsThis multi-center retrospective study included patients who underwent surgical resection for suspected brain metastasis progression after SRS. Presurgical FLAIR and postcontrast T1 (T1w-ce) were segmented using a convolutional neural network (CNN) and compared with manual segmentation by means of Dice score. Radiomics features were extracted from each lesion, and a Random Forest model was trained on 70% of the internal dataset and evaluated on the remaining 30% and the complete external dataset. A 3DResNet-CNN was trained on the same split dataset. Validation was performed on the external dataset. Postsurgical histology was available for all cases.

resultsOne hundred and twenty four brain metastases were included (104 from center 1 and 20 from center 2). Sole radionecrosis was histologically detected in 34 cases (27.4%). In the internal dataset, univariate and multivariate analysis identified 131 significantly different radiomics features, including GLDM_DNUN and GLDM_SDE within the enhancing area on the T1w-ce. On the external test dataset, the Random Forest model and the 3DResNet-CNN yielded accurate results in terms of accuracy (80.0%, 85.0%), AUROC (0.830, 0.893) and sensitivity (92.8%, 100%) in radionecrosis prediction, respectively.

conclusionArtificial intelligence could be employed to differentiate between radionecrosis and brain metastasis progression upon SRS, potentially reducing unnecessary surgical interventions.

Indexed as

Brain NeoplasmsNeural Networks, ComputerRadiation InjuriesRadiosurgeryAdultAgedAged, 80 and overDisease ProgressionFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleMiddle AgedNecrosisPrognosisbrain metastasisbrain MRIdeep learningmachine learningstereotactic radiosurgery

Identifiers

PMID40172476
PMCPMC12908478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.